Clinical trials
Phase 1 Hematologic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Institut Paoli-Calmettes | 2 |
| Janssen Research & Development, LLC | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| Genentech, Inc. | 1 |
| Immunome, Inc. | 1 |
| Incyte Corporation | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Jazz Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 18 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Myelodysplastic Syndromes | 3 |
| Recurrence | 3 |
| Hodgkin Disease | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Neoplasms | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.